Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: An analysis based on ESPOIR cohort data

Annals of the Rheumatic Diseases

Volumn 71, Issue 3, 2012, Pages 386-389

  Fautrel, B ^a   Combe, B ^b   Rincheval, N ^b   Dougados, M ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; ARTHRALGIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; REPRODUCIBILITY OF RESULTS; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84857236812     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200259     Document Type: Article

References (20)

1. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
2. van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007;56:1424-32. (Pubitemid 46764069)
3. Saraux A, Berthelot JM, Chalès G, et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 2001;44:2485-91. (Pubitemid 33049326)
4. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.
5. Combe B, Benessiano J, Berenbaum F, et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007;74:440-5. (Pubitemid 47588984)
6. Combe B. The French early arthritis registry. Clin Exp Rheumatol 2003; 21:S123-8. (Pubitemid 37265601)
7. Combe B, Landewe R, Lukas as C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34-45.
8. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59:762-84. (Pubitemid 351847559)
9. Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010; 69:631-7.
10. Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51. (Pubitemid 33016415)
11. Lukas C, Combe B, Ravaud P, et al. Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: data from the Etude et Suivi des Polyarthrites Indifferenciees Recentes (study and followup of early undifferentiated polyarthritis). Arthritis Rheum 2011; 63:1804-11.
12. Escalas C, Dalichampt M, Combe B, et al. Effect of adherence to European treatment guidelines on early arthritis outcome: data from the ESPOIR cohort. Arthritis Rheum 2011; 60:S378.
13. Neogi T, Aletaha D, Silman AJ, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum 2010; 62:2582-91.
14. Britsemmer K, Ursum J, Gerritsen M, et al. Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria. Ann Rheum Dis 2011;70:1468-70.
15. Cader MZ, Filer A, Hazlehurst J, et al. Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Ann Rheum Dis 2011;70:949-55.
16. van der Linden MP, Knevel R, Huizinga TW, et al. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum 2011;63:37-42.
17. Morvan J, Berthelot JM, Devauchelle-Pensec V, et al. Changes over time in the diagnosis of rheumatoid arthritis in a 10-year cohort. J Rheumatol 2009; 36:2428-34.
18. Fautrel B. Diagnosing early or rheumatoid arthritis. Which is better: expert opinion or evidence? J Rheumatol 2009; 36:2375-7.
19. Liao KP, Batra KL, Chibnik L, et al. Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis 2008;67:1557-61.
20. Zeidler H. How can misclassification be prevented when using the 2010 American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis classification criteria? Comment on the article by van der Linden et al. Arthritis Rheum 2011; 63:2544-6; author reply 456.